SUNNYVALE, Calif., May 24, 2017 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today it has appointed,
Stan Gee, who has been with Accuray
for over eight years, to the newly created Vice President of
Revenue Management position reporting to Kevin Waters, Chief Financial Officer. Mr. Gee
will be responsible for driving the global revenue forecast and
overseeing the order to revenue conversion process for the
Company. In his new role, Mr. Gee will be working closely
with Accuray's customers, regional installation, service and
commercial teams to improve the overall timing and cadence of
system installation and ultimately revenue conversion, specifically
in those regions where distributor initiated orders have become a
bigger part of the overall order mix in backlog.
"During his eight-year career with Accuray, Stan has proven to
be an exceptional leader and has developed a reputation within our
organization for meeting objectives and achieving results," said
Mr. Waters. "We have a high degree of confidence he will lead
our new initiatives in revenue management and conversion with a
renewed sense of urgency and focus."
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company
that develops, manufactures, and sells precise, innovative tumor
treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The company's
leading-edge technologies deliver the full range of radiation
therapy and radiosurgery treatments. For more information, please
visit www.accuray.com.
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited, to Accuray's company
trajectory, including without limitation the anticipated impact on
the company's ability to convert backlog into revenue, and
Accuray's leadership position in radiation oncology innovation.
Forward-looking statements are subject to risks and uncertainties
that could cause actual results to differ materially from
expectations, including but not limited to the risks detailed from
time to time under the heading "Risk Factors" in the company's
report on Form 10-K, filed on August 24,
2016, the company's reports on Form 10-Q, filed on
November 1, 2016, February 3, 2017, and May
5, 2017, and as updated periodically with the company's
other filings with the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to
Accuray at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Investor Contact:
Doug Sherk
Investor Relations, EVC Group
+1 (415) 652-9100
dsherk@evcgroup.com
Media Contacts:
Beth Kaplan
Accuray
+1 (408) 789-4426
bkaplan@accuray.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/accuray-appoints-stan-gee-vp-of-revenue-management-300462802.html
SOURCE Accuray Incorporated